1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; 70:7–30.
Article
2. Hong S, Won YJ, Park YR, Jung KW, Kong HJ, Lee ES, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat. 2020; 52:335–50.
Article
3. Sung H, Freedman RA, Siegel RL, Hyun N, DeSantis CE, Ruddy KJ, et al. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status. Cancer. 2021; 127:3310–24.
Article
4. Kang D, Kang M, Hong YS, Park J, Lee J, Seo HJ, et al. Temporal patterns of chronic disease incidence after breast cancer: a nationwide population-based cohort study. Sci Rep. 2022; 12:5489.
Article
5. Lee G, Park SM. Health screening for cancer survivors. Korean J Fam Pract. 2022; 12:2–8.
Article
6. Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol. 2016; 34:611–35.
Article
7. Yoo KY. Cancer control activities in the Republic of Korea. Jpn J Clin Oncol. 2008; 38:327–33.
Article
8. Suh M, Song S, Cho HN, Park B, Jun JK, Choi E, et al. Trends in participation rates for the National Cancer Screening Program in Korea, 2002-2012. Cancer Res Treat. 2017; 49:798–806.
Article
9. Hong S, Lee YY, Lee J, Kim Y, Choi KS, Jun JK, et al. Trends in cancer screening rates among Korean men and women: results of the Korean National Cancer Screening Survey, 2004-2018. Cancer Res Treat. 2021; 53:330–8.
Article
10. Lee K, Kim H, Lee JH, Jeong H, Shin SA, Han T, et al. Retrospective observation on contribution and limitations of screening for breast cancer with mammography in Korea: detection rate of breast cancer and incidence rate of interval cancer of the breast. BMC Womens Health. 2016; 16:72.
Article
11. Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual percent change in trend analysis. Stat Med. 2009; 28:3670–82.
12. Lowry KP, Callaway KA, Lee JM, Zhang F, Ross-Degnan D, Wharam JF, et al. Trends in annual surveillance mammography participation among breast cancer survivors from 2004 to 2016. J Natl Compr Canc Netw. 2022; 20:379–86.
Article
13. Lee EA, Shin J, Hwang EJ, Lee JW. Breast and cervical cancer screening behavior in female cancer survivors: the Korea National Health and Nutrition Examination Survey, 2007-2012. Korean J Fam Med. 2017; 38:116–21.
Article
14. Cho J, Guallar E, Hsu YJ, Shin DW, Lee WC. A comparison of cancer screening practices in cancer survivors and in the general population: the Korean national health and nutrition examination survey (KNHANES) 2001-2007. Cancer Causes Control. 2010; 21:2203–12.
Article
15. Kang SY, Kim YS, Kim Z, Kim HY, Lee SK, Jung KW, et al. Basic findings regarding breast cancer in Korea in 2015: data from a breast cancer registry. J Breast Cancer. 2018; 21:1–10.
Article
16. Zeng H, Zheng R, Zhang S, Zou X, Chen W. Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries. J Thorac Dis. 2014; 6:466–70.
18. Dash C, Lu J, Parikh V, Wathen S, Shah S, Shah Chaudhari R, et al. Disparities in colorectal cancer screening among breast and prostate cancer survivors. Cancer Med. 2021; 10:1448–56.
Article
19. MacDonald M, Mirza AS, Mhaskar R, Ewing A, Chen L, Robinson K, et al. Preventative cancer screening rates among uninsured patients in free clinics: a retrospective cohort study of Cancer survivors and non-cancer survivors. Cancer Control. 2022; 29:10732748211072983.
Article
20. Millar MM, Edwards SL, Herget KA, Orleans B, Ofori-Atta BS, Kirchhoff AC, et al. Adherence to guideline-recommended cancer screening among Utah cancer survivors. Cancer Med. 2023; 12:3543–54.
21. Clarke TC, Soler-Vila H, Fleming LE, Christ SL, Lee DJ, Arheart KL. Trends in adherence to recommended cancer screening: the US population and working cancer survivors. Front Oncol. 2012; 2:190.
Article
22. Corkum M, Hayden JA, Kephart G, Urquhart R, Schlievert C, Porter G. Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis. J Cancer Surviv. 2013; 7:455–63.
Article
23. Uhlig A, Mei J, Baik I, Meyer C, Uhlig J. Screening utilization among cancer survivors: a meta-analysis. J Public Health (Oxf). 2018; 40:129–37.
Article
24. Khan NF, Carpenter L, Watson E, Rose PW. Cancer screening and preventative care among long-term cancer survivors in the United Kingdom. Br J Cancer. 2010; 102:1085–90.
Article
25. Kang HT. Current status of the National Health Screening Programs in South Korea. Korean J Fam Med. 2022; 43:168–73.
Article
26. Kim YS, Kang HT, Lee JW. The association between cancer screening and cancer history among Korean adults: the 2010-2012 Korea National Health and Nutrition Examination Survey. Korean J Fam Med. 2019; 40:307–13.
Article
27. Hahm MI, Chen HF, Miller T, O’Neill L, Lee HY. Why do some people choose opportunistic rather than organized cancer screening? The Korean National Health and Nutrition Examination Survey (KNHANES) 2010-2012. Cancer Res Treat. 2017; 49:727–38.
Article
28. Yang MS, Park M, Back JH, Lee GH, Shin JH, Kim K, et al. Validation of cancer diagnosis based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea. Cancer Res Treat. 2022; 54:352–61.
Article
29. Korea Central Cancer Registry; National Cancer Center. Annual report of cancer statistics in Korea in 2017. Sejong: Ministry of Health and Welfare;2019.